Search Results | Blood | American Society of Hematology

1-20 of 383

Sort by

Sort Order Select

Journal Articles

Towards Higher Safety of Haemato-Oncological Patients Undergoing Treatment

Tereza Popkova, MD, Katarina Hradska, MD, Jana Mihalyova, MD, Michaela Skorupova, Tomas Jelinek, MD, Juraj Duras, MD, Zdenek Koristek, MD PhD, Milan Navratil, MD, Katerina Benkova, MD, Hana Plonkova, MD, Jana Zuchnicka, MD, Jaromir Gumulec, MD, Roman Hajek, Prof, MD PhD

Blood (2019) 134 (Supplement_1): 4757.

DOI: https://doi.org/10.1182/blood-2019-127011

Published: 2019

Journal Articles

Ethical Issues and Barriers for Multi-National Paediatric Clinical Trials: The Challenging Experience of the DEEP Project

Viviana Giannuzzi, PhD, Mariagrazia Felisi, PhD, Hugo Devlieger, Aurelio Maggio, MD, George Papanikolaou, MD PhD, Giorgio Reggiardo, Bianca Tempesta, PhD, Fernando Tricta, MD, Donato Bonifazi

Blood (2019) 134 (Supplement_1): 4820.

DOI: https://doi.org/10.1182/blood-2019-124689

Published: 2019

Journal Articles

Impact of Antibiotics on Gut Microbiota Diversity and the Results of a Prospective Dietary Assessment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Christopher D'Angelo, MD, Sailendharan Sudakaran, PhD, Peiman Hematti, MD, Fotis Asimakopoulos, PhDMBBChir,, Craig Augustine, MBA, Nasia Safdar, MD PhD, Natalie Scott Callander, MD

Blood (2019) 134 (Supplement_1): 4653.

DOI: https://doi.org/10.1182/blood-2019-123530

Published: 2019

Journal Articles

Real-World Treatment Patterns and Clinical Outcomes in Multiple Myeloma in the Asia-Pacific Region: Methodology and Preliminary Results of the Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR)

Naomi Aoki, MSc, BSc, Elizabeth M. Moore, PhD, Erica M. Wood, MBBS, FRACP, FRCPA, Zoe McQuilten, Cameron Wellard, Andrew Spencer, MBBS, FRACP, FRCPA, DM

Blood (2019) 134 (Supplement_1): 5518.

DOI: https://doi.org/10.1182/blood-2019-124256

Published: 2019

Journal Articles

Combination of ATRA and High-Dose Dexamethasone As First-Line Treatment in Adult Immune Thrombocytopenia:a Randomized, Phase 2, Open-Label Trial

Qiu-Sha Huang, Yi Liu, Jing-Bo Wang, Jun Peng, Ming Hou, Hui Liu, Jing-Wen Wang, Lan-Ping Xu, Kaiyan Liu, Xiao-Jun Huang, MD, Xiao-Hui Zhang

Blood (2019) 134 (Supplement_1): 899.

DOI: https://doi.org/10.1182/blood-2019-125242

Published: 2019

Journal Articles

A Cross-Sectional Study Examining the Effects of Patient Information Level on Healthcare Experience in 2 Patient Populations: Extranodal Natural Killer T-Cell Lymphoma (ENKTL) and Waldenstrom Macroglobulinemia (WM)

Natalie M Dren, BSc, MPH, Lorna E Warwick, BA, B Ed, Olufunmilayo A Bamigbola, MB;BS, MSc (Epid)

Blood (2019) 134 (Supplement_1): 3422.

DOI: https://doi.org/10.1182/blood-2019-123479

Published: 2019

Journal Articles

Registration Errors Among Patients Receiving Blood Transfusions: A National Analysis from 2008-2017

Shangari Vijenthira, Chantal Armali, Helen Downie, Ann Wilson, Kathy Paton, Brian Berry, Christine Cserti-Gazdewich, Jeannie Callum

Blood (2019) 134 (Supplement_1): 3689.

DOI: https://doi.org/10.1182/blood-2019-130615

Published: 2019

Journal Articles

Sickle-Cell Disease in Greece: Patient Reported Outcomes Related to Clinical Complications, Treatment Choices and Attitudes, Beliefs and Trends Affecting Potential Participation in Clinical Trials - a Greek National Multicentric Study

Sophia Delicou, Michael D. Diamantidis, MD PhD MSc, Konstantinos Manganas, Eftychios Eftychiadis, MD, Despoina Pantelidou, MD PhD, Alexandra Kourakli, MD PhD, Efthymia Vlachaki, MBBS, Loukia Evliati, Ioannis Lafiatis, Evangelos Klironomos, MD, Dimitra Kyriakopoulou, MD, Aikaterini Xydaki, Vassiliki Bartzi, Despoina Papadopoulou, Vasileios Lazaris, Chrysoula Apostolou, Antonis Kattamis, Argiris Symeonidis, MD PhD

Blood (2019) 134 (Supplement_1): 4838.

DOI: https://doi.org/10.1182/blood-2019-127966

Published: 2019

Journal Articles

Myeloproliferative Neoplasm (MPN) Patient Online Questionnaire: Assessing Patients' Disease Knowledge in a Rare Hematologic Malignancy in the Modern Digital Information Era

Naveen Pemmaraju, MD, Theresa Clementi, Wei Qiao, PhD, Susan K Peterson, PhD, Vicky Zoeller, Andrew J. Schorr, Srdan Verstovsek, MD PhD

Blood (2019) 134 (Supplement_1): 1670.

DOI: https://doi.org/10.1182/blood-2019-129545

Published: 2019

Journal Articles

The Development of Ironchild: A Web-Based Intervention to Improve Adherence in Children with Iron Deficiency Anemia

Jacquelyn M. Powers, MD,MSc, Deborah I Thompson, PhD

Blood (2019) 134 (Supplement_1): 2163.

DOI: https://doi.org/10.1182/blood-2019-124181

Published: 2019

Journal Articles

Late Effects Are Important Considerations in Initial Hodgkin Lymphoma Treatment Decision-Making According to Survivors

Anita J Kumar, MDMS, Rachel Murphy-Banks, MA, Ruth Ann Weidner, MBA, MRP, Susan K Parsons, MD MRP

Blood (2019) 134 (Supplement_1): 2137.

DOI: https://doi.org/10.1182/blood-2019-124481

Published: 2019

Journal Articles

Perceptions of Community Hematologists/Oncologists on Barriers to Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Diffuse Large B-Cell Lymphoma

Ajeet Gajra, MD FACP, Richard Sweat, PhD, Yolaine Jeune-Smith, PhD, Jonathan K. Kish, PhD MPH, Bruce A Feinberg, DO

Blood (2019) 134 (Supplement_1): 2198.

DOI: https://doi.org/10.1182/blood-2019-127741

Published: 2019

Journal Articles

The Development and Application of a Clinical Severity Scoring Model for Post-Operative Venous Thromboembolism (VTE)

Aleksandra Kajetanowicz, BSc, Sudeep P Shivakumar, MD BSc, Steve Doucette, MSc, Susan Pleasance, BSN, Christopher Green, MD, Allen Tran, MDBSc, David R. Anderson, MD

Blood (2019) 134 (Supplement_1): 1148.

DOI: https://doi.org/10.1182/blood-2019-129140

Published: 2019

Journal Articles

Physicians' and Patients' Perspectives on Treatments in ITP - a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh)

James B. Bussel, MD, Waleed Ghanima, MD PhD, Yoshiaki Tomiyama, MD, Donald M. Arnold, MD, Drew Provan, MD, Ming Hou, MD PhD, Cristina Santoro, MD PhD, Serge Laborde, Alexandra Kruse, Caroline Kruse, Mervyn Morgan, Barbara Lovrencic, John Waller, PhD, Jens Haenig, Nichola Cooper, MD MRCP

Blood (2019) 134 (Supplement_1): 1097.

DOI: https://doi.org/10.1182/blood-2019-130591

Published: 2019

Journal Articles

Definition and Validation of the New Elderly Prognostic Index (EPI) for Elderly Patients with Diffuse Large B-Cell Lymphoma Integrating Geriatric and Clinical Assessment: Results of the Prospective "Elderly Project" on 1353 Patients By the Fondazione Italiana Linfomi

Blood (2019) 134 (Supplement_1): 398.

DOI: https://doi.org/10.1182/blood-2019-123027

Published: 2019

Journal Articles

Therapeutic Plasma Exchange in Pediatrics for Immunologic Disorders; Tolerated and Safe Process for Pediatric Life-Threatening Conditions

Blood (2019) 134 (Supplement_1): 4986.

DOI: https://doi.org/10.1182/blood-2019-122106

Published: 2019

Journal Articles

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

Blood (2019) 134 (Supplement_1): 2843.

DOI: https://doi.org/10.1182/blood-2019-126661

Published: 2019

Journal Articles

FBXO11 Is a Candidate Tumor Suppressor in the Transformation of MDS to Secondary AML

Michael Schieber, MD, John D. Crispino, PhD MBA

Blood (2019) 134 (Supplement_1): 4217.

DOI: https://doi.org/10.1182/blood-2019-124007

Published: 2019

Journal Articles

Cancer and E-Health: Evidences and Contributes Emerging from a Social Network Page Dedicated to Onco-Hematological Diseases

Rossana Botto, Manuela Prencipe, PsyD, Valentina Ieraci, PhD, Umberto Vitolo, Riccardo Torta, MD

Blood (2019) 134 (Supplement_1): 5853.

DOI: https://doi.org/10.1182/blood-2019-123009

Published: 2019

Journal Articles

Understanding the Association between Transfusion Status (TS) and Overall Survival (OS), and Other Clinical Outcomes in Patients with Myelodysplastic Syndromes (MDS) from the Physicians' Perspective: A Pilot Survey

Shaloo Gupta, Zhiyi Li, Thomas Schroeder, MD, Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Joana E. Matos, Alexandra Berk, Derek Tang, PhD BSPharm, Jay Grisolano

Blood (2019) 134 (Supplement_1): 5901.

DOI: https://doi.org/10.1182/blood-2019-122725

Published: 2019

NARROW

Towards Higher Safety of Haemato-Oncological Patients Undergoing Treatment

Ethical Issues and Barriers for Multi-National Paediatric Clinical Trials: The Challenging Experience of the DEEP Project

Impact of Antibiotics on Gut Microbiota Diversity and the Results of a Prospective Dietary Assessment in Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation

Real-World Treatment Patterns and Clinical Outcomes in Multiple Myeloma in the Asia-Pacific Region: Methodology and Preliminary Results of the Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR)

Combination of ATRA and High-Dose Dexamethasone As First-Line Treatment in Adult Immune Thrombocytopenia:a Randomized, Phase 2, Open-Label Trial

A Cross-Sectional Study Examining the Effects of Patient Information Level on Healthcare Experience in 2 Patient Populations: Extranodal Natural Killer T-Cell Lymphoma (ENKTL) and Waldenstrom Macroglobulinemia (WM)

Registration Errors Among Patients Receiving Blood Transfusions: A National Analysis from 2008-2017

Sickle-Cell Disease in Greece: Patient Reported Outcomes Related to Clinical Complications, Treatment Choices and Attitudes, Beliefs and Trends Affecting Potential Participation in Clinical Trials - a Greek National Multicentric Study

Myeloproliferative Neoplasm (MPN) Patient Online Questionnaire: Assessing Patients' Disease Knowledge in a Rare Hematologic Malignancy in the Modern Digital Information Era

The Development of Ironchild: A Web-Based Intervention to Improve Adherence in Children with Iron Deficiency Anemia

Late Effects Are Important Considerations in Initial Hodgkin Lymphoma Treatment Decision-Making According to Survivors

Perceptions of Community Hematologists/Oncologists on Barriers to Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Diffuse Large B-Cell Lymphoma

The Development and Application of a Clinical Severity Scoring Model for Post-Operative Venous Thromboembolism (VTE)

Physicians' and Patients' Perspectives on Treatments in ITP - a Multi-Country Perspective: Results from the ITP World Impact Survey (I-WISh)

Definition and Validation of the New Elderly Prognostic Index (EPI) for Elderly Patients with Diffuse Large B-Cell Lymphoma Integrating Geriatric and Clinical Assessment: Results of the Prospective "Elderly Project" on 1353 Patients By the Fondazione Italiana Linfomi

Therapeutic Plasma Exchange in Pediatrics for Immunologic Disorders; Tolerated and Safe Process for Pediatric Life-Threatening Conditions

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adulthood - a Randomized, Placebo-Controlled Double Blinded Phase IIb Trial

FBXO11 Is a Candidate Tumor Suppressor in the Transformation of MDS to Secondary AML

Cancer and E-Health: Evidences and Contributes Emerging from a Social Network Page Dedicated to Onco-Hematological Diseases

Understanding the Association between Transfusion Status (TS) and Overall Survival (OS), and Other Clinical Outcomes in Patients with Myelodysplastic Syndromes (MDS) from the Physicians' Perspective: A Pilot Survey

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only